Usage of Synaffix GlycoConnect, HydraSpace and toxSYN ADC technologies to enhance efficacy, tolerability and target engagement
India's bio economy has experienced remarkable growth, skyrocketing from $10 billion in 2014 to over $130 billion in 2024, with projections to reach $300 billion by 2030
The session focused on “Biomanufacturing of Enzymes,” a critical domain under the BioE3 Policy.
Exploring new opportunities within the fast-growing market of microfluidics
ActivShield technology is a portable, novel sterilization modality that does not require conventional infrastructure
MoU signed to drive digital transformation through strategic projects across all three business sectors of Merck
This partnership aims to accelerate research and development into innovative treatments and, if successful, will generate milestones and royalties
Revolutionary technology will further boost OneSource’s scientific services offerings
The acquisition of LumiraDx’s Point of Care technology received all required antitrust and regulatory clearances
Aim of the collaboration is to develop mRNA platform technology, scale up and troubleshoot challenges in mRNA process optimization
Subscribe To Our Newsletter & Stay Updated
